DNA variants may influence response to inhaled bronchodilators by patients with COPD, scientists report at ASHG 2013
NEWS For more information: Cathy Yarbrough press@ashg.org sciencematter@yahoo.com 858-243-1814 Embargo: 8 a.m. ET, Friday, Oct. 25, 2013 Several novel gene variants may help explain the response of patients with chronic obstructive pulmonary disease (COPD) to inhaled bronchodilators, according to a meta-analysis reported today (Oct. 25) at the American Society of Human Genetics 2013 meeting in... Read More